ASX - By Stock
|
PAA |
Re:
Pipeline-in-a-drug
|
|
Havenots
|
52 |
8.0K |
4 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
52
|
8.0K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Pipeline-in-a-drug
|
|
Havenots
|
52 |
8.0K |
8 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
52
|
8.0K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
BIG FREEZE - CHILLS AND THRILLS
|
|
Havenots
|
11 |
2.7K |
9 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
11
|
2.7K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Havenots
|
495 |
112K |
10 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
495
|
112K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Havenots
|
495 |
112K |
13 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
495
|
112K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
BIG FREEZE - CHILLS AND THRILLS
|
|
Havenots
|
11 |
2.7K |
12 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
11
|
2.7K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust - Media & News
|
|
Havenots
|
21 |
5.8K |
19 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
21
|
5.8K
|
19
|
|
ASX - By Stock
|
PAA Biotech |
Re:
BIG FREEZE - CHILLS AND THRILLS
|
|
Havenots
|
11 |
2.7K |
10 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
11
|
2.7K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
BIG FREEZE - CHILLS AND THRILLS
|
|
Havenots
|
11 |
2.7K |
5 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
11
|
2.7K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust - Media & News
|
|
Havenots
|
21 |
5.8K |
36 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
21
|
5.8K
|
36
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Havenots
|
495 |
112K |
31 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
495
|
112K
|
31
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Havenots
|
495 |
112K |
22 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
495
|
112K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
Havenots
|
85 |
20K |
14 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
20K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
Havenots
|
85 |
20K |
45 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
20K
|
45
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
Havenots
|
85 |
20K |
22 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
20K
|
22
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Havenots
|
495 |
112K |
9 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
495
|
112K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Havenots
|
495 |
112K |
21 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
495
|
112K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
Havenots
|
58 |
15K |
29 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
58
|
15K
|
29
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Havenots
|
495 |
112K |
43 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
495
|
112K
|
43
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Havenots
|
495 |
112K |
24 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
495
|
112K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
Havenots
|
58 |
15K |
22 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
58
|
15K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust receives Orphan Drug Designation for monepantel
|
|
Havenots
|
43 |
11K |
25 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
43
|
11K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust receives Orphan Drug Designation for monepantel
|
|
Havenots
|
43 |
11K |
20 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
43
|
11K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Havenots
|
495 |
112K |
16 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
495
|
112K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
Havenots
|
86 |
20K |
44 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
20K
|
44
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
Havenots
|
58 |
15K |
13 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
58
|
15K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Havenots
|
495 |
112K |
10 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
495
|
112K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Havenots
|
495 |
112K |
12 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
495
|
112K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Havenots
|
495 |
112K |
25 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
495
|
112K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
Havenots
|
86 |
20K |
40 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
86
|
20K
|
40
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Havenots
|
239 |
63K |
13 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
239
|
63K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Havenots
|
239 |
63K |
27 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
239
|
63K
|
27
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Havenots
|
239 |
63K |
22 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
239
|
63K
|
22
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
Havenots
|
32 |
9.8K |
13 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
32
|
9.8K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Havenots
|
239 |
63K |
22 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
239
|
63K
|
22
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Havenots
|
1.4K |
358K |
9 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
1.4K
|
358K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Havenots
|
1.4K |
358K |
33 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
1.4K
|
358K
|
33
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
Havenots
|
12 |
2.8K |
6 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12
|
2.8K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
Havenots
|
12 |
2.8K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12
|
2.8K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
Havenots
|
12 |
2.8K |
9 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12
|
2.8K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
Havenots
|
62 |
17K |
13 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
17K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
Havenots
|
62 |
17K |
7 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
17K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Havenots
|
33 |
8.8K |
24 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
33
|
8.8K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Havenots
|
126 |
32K |
8 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
32K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Havenots
|
222 |
47K |
5 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
222
|
47K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Havenots
|
222 |
47K |
3 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
222
|
47K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Havenots
|
58 |
15K |
23 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
58
|
15K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Havenots
|
58 |
15K |
15 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
58
|
15K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Havenots
|
77 |
20K |
7 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
77
|
20K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Havenots
|
1.4K |
358K |
22 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
1.4K
|
358K
|
22
|
|